Search filters

List of works by Dimitrios C Ziogas

A Network Meta-analysis of Randomized Controlled Trials of Induction Treatments in Acute Myeloid Leukemia in the Elderly ⬇️

scientific article published on March 1, 2011

A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options

scientific article published on 21 January 2019

An overview of antibody-drug conjugates in oncological practice

scientific article published on 04 October 2020

Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group

scientific article published on 06 March 2019

Bone mineral density and genetic markers involved in three connected pathways (focal adhesion, actin cytoskeleton regulation and cell cycle): the CUMAGAS-BMD information system ⬇️

scientific article published on November 8, 2011

Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.

scientific article published on 4 April 2016

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

scientific article published on 27 February 2017

Carfilzomib for treating myeloma

Clinical considerations about the coexistence of melanoma and chronic lymphocytic leukemia in the era of targeted therapies, triggered by rare clinical scenarios. A case series and review of the literature

scientific article published on 05 October 2020

Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases

Combination of conventional culture, vial culture, and broad-range PCR of sonication fluid for the diagnosis of prosthetic joint infection

scientific article published on 21 April 2018

Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates

scientific article published on 10 January 2019

Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies

scientific article published on 19 July 2018

Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis

scientific article published on 01 December 2018

Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM

scientific article published on 23 August 2018

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.

scientific article published on 24 May 2018

Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma

scientific article

Evidence of Association Between Methylenetetrahydrofolate Reductase Gene and Susceptibility to Breast Cancer: A Candidate-Gene Association Study in a South-Eastern European Population ⬇️

scientific article published on August 29, 2011

Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis

scientific article published on 31 January 2018

Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.

scientific article

Identifying the optimum first-line therapy in BRAF-mutant metastatic melanoma

scientific article published on 07 January 2020

Immunotherapy for pancreatic cancer: A 2020 update

scientific article published on 25 March 2020

Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

scientific article published on 01 October 2019

Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone

scientific article published on 01 December 2019

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

scientific article published on 01 October 2019

Prognosis and Management of BRAF V600E-Mutated Pregnancy-Associated Melanoma

scientific article published on 09 April 2020

Prognostic factors for multiple myeloma in the era of novel therapies

scientific article published on 26 October 2018

Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome

scientific article published on 05 March 2019

Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations

scientific article published on 04 September 2019

Reduced Intestinal Tumorigenesis in APCmin Mice Lacking Melanin-Concentrating Hormone ⬇️

scientific article published on July 27, 2012

Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy

scientific article published on 28 March 2017

The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents

scientific article published on 22 November 2017

The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates ⬇️

scientific article published on June 25, 2012

Treating ALK-positive non-small cell lung cancer.

scientific article

Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients

scientific article published on 10 January 2019

Paulina is supported by:

About Paulina

Help